1 |
Gammill HS, Jeyabalan A. Acute renal failure in pregnancy [J].Crit Care Med,2005,33(10 Suppl): S372-384.
|
2 |
Kuklina EV, Ayala C, Callaghan WM. Hypertensive disorders and severe obstetric morbidity in the United States [J]. Obstet Gynecol,2009,113(6):1299-1306.
|
3 |
Martin JN Jr, Blake PG, Perry KG Jr, et al. The natural history of HELLP syndrome: patterns of disease progression and regression[J]. Am J Obstet Gynecol,1991,164 (6 Pt 1): 1500-1509;discussion 1509-1513.
|
4 |
Acharya A, Santos J, Linde B, et al. Acute kidney injury in pregnancy-current status [J]. Adv Chronic Kidney Dis, 2013, 20(3):215-222.
|
5 |
Fakhouri F, Vercel C, Fremeaux-Bacchi V. Obstetric nephrology:AKI and thrombotic microangiopathies in pregnancy [J]. Clin J Am Soc Nephrol,2012,7(12):2100-2106.
|
6 |
Youssef A, Righetti F, Morano D, et al. Uterine artery Doppler and biochemical markers (PAPP-A, PIGF, sFlt-1, P-selectin, NGAL)at 11 +0 to 13 +6 weeks in the prediction of late ( > 34 weeks)pre-eclampsia [J]. Prenat Diagn,2011,31(12):1141-1146.
|
7 |
Adrogue HJ, Madias NE. Management of life-threatening acid-base disorders. First of two parts [J]. N Engl J Med,1998,338(1):26-34.
|
8 |
Andres RL, Saade G, Gilstrap LC, et al. Association between umbilical blood gas parameters and neonatal morbidity and death in neonates with pathologic fetal acidemia [J]. Am J Obstet Gynecol,1999,181(4):867-871.
|
9 |
Machado S, Figueiredo N, Borges A, et al. Acute kidney injury in pregnancy:a clinical challenge [J]. J Nephrol,2012,25(1):19-30.
|
10 |
Al-Safi Z, Imudia AN, Filetti LC, et al. Delayed postpartum preeclampsia and eclampsia: demographics, clinical course, and complications [J]. Obstet Gynecol,2011,118(5):1102-1107.
|
11 |
Johnson RJ, Kanbay M, Kang DH, et al. Uric acid: a clinically useful marker to distinguish preeclampsia from gestational hypertension [J]. Hypertension,2011,58(4):548-549.
|
12 |
Silasi M, Cohen B, Karumanchi SA, et al. Abnormal placentation,angiogenic factors,and the pathogenesis of preeclampsia[J]. Obstet Gynecol Clin North Am,2010,37(2):239-253.
|
13 |
Villa PM, Kajantie E, Raikkonen K, et al. Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials [J]. BJOG,2013,120(1):64-74.
|
14 |
Publications Committee SfM-FM, Sibai BM. Evaluation and management of severe preeclampsia before 34 weeks' gestation [J]Am J Obstet Gynecol,2011,205(3):191-198.
|
15 |
Townsley DM. Hematologic complications of pregnancy [J]. Semin Hematol,2013,50(3):222-231.
|
16 |
George JN. How I treat patients with thrombotic thrombocytopenic purpura:2010 [J]. Blood,2010,116(20):4060-4069.
|
17 |
Scully M,Hunt BJ,Benjamin S,et al. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies [J]. Br J Haematol,2012,158(3):323-335.
|
18 |
Gall B, Yee A, Berry B, et al. Rituximab for management of refractory pregnancy-associated immune thrombocytopenic purpura[J]. J Obstet Gynaecol Can,2010,32(12):1167-1171.
|
19 |
Vesely SK, Li X, McMinn JR, et al. Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome [J]. Transfusion,2004,44(8):1149-1158.
|
20 |
Skerka C,Jozsi M,Zipfel PF,et al. Autoantibodies in haemolytic uraemic syndrome (HUS) [J]. Thromb Haemost,2009,101(2):227-232.
|
21 |
Woodruff TM, Nandakumar KS, Tedesco F. Inhibiting the C5-C5a receptor axis [J]. Mol Immunol,2011,48(14):1631-1642.
|
22 |
Kelly R, Arnold L, Richards S, et al. The management of pregnancy in paroxysmal nocturnal haemoglobinuria on long term eculizumab [J]. Br J Haematol,2010,149(3):446-450.
|
23 |
Knight M, Nelson-Piercy C, Kurinczuk JJ, et al. A prospective national study of acute fatty liver of pregnancy in the UK [J]. Gut,2008,57(7):951-956.
|
24 |
Lee NM, Brady CW. Liver disease in pregnancy [J]. World J Gastroenterol,2009,15(8):897-906.
|
25 |
Podymow T, August P, Akbari A. Management of renal disease in pregnancy [J]. Obstet Gynecol Clin North Am, 2010, 37(2):195-210.
|